Showing results (41-50 of 112) with videos related to
Sort By:
Pageof 12
European Journal of Heart Failure|January 6, 2012
Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challengeCarlo G Tocchetti, Gianluca Ragone, Carmela Coppola, et al.Journal of Clinical Medicine|August 14, 2025
Atrial Fibrillation and Cancer: Pathophysiological Mechanism and Clinical ImplicationsAlfredo Mauriello, Adriana Correra, Vincenzo Quagliariello, et al.International Journal of Molecular Sciences|October 24, 2020
NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer CellsVincenzo Quagliariello, Michelino De Laurentiis, Stefania Cocco, et al.International Journal of Molecular Sciences|October 16, 2025
Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic ImplicationsDalila Incognito, Giuliana Ciappina, Claudia Gelsomino, et al.Frontiers in Cardiovascular Medicine|March 18, 2022
Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-OncologyMaria Laura Canale, Katia Coviello, Gianluca Solarino, et al.Journal of Clinical Medicine|February 26, 2025
Genetic Background in Patients with Cancer Therapy-Induced CardiomyopathyLuca Fazzini, Nicola Campana, Stefano Cossu, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 17, 2016
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of CardiologyPaolo Spallarossa, Nicola Maurea, Christian Cadeddu, et al.Frontiers in Cardiovascular Medicine|November 27, 2025
Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysisLuca Fazzini, Simone Angius, Nicola Campana, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 17, 2016
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of CardiologyNicola Maurea, Paolo Spallarossa, Christian Cadeddu, et al.Advances in Therapy|May 22, 2020
Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving ImmunotherapyMaria Laura Canale, Andrea Camerini, Giancarlo Casolo, et al.Pageof 12